Vireo Growth (VREOF) Capital Expenditures (2020 - 2026)
Vireo Growth's (VREOF) quarterly Capital Expenditures came in at $10.8 million in Q1 2026, up 881.82% year-on-year from $1.1 million in Q1 2025, and up 9.51% quarter-over-quarter from $9.9 million in Q4 2025.
Vireo Growth (VREOF) Capital Expenditures (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Capital Expenditures across 7 years of filings, most recently posting $10.8 million for Q1 2026.
- Capital Expenditures for Q1 2026 came in at $10.8 million, up 881.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $38.0 million (up 219.65% YoY), and the FY2025 annual result was $28.3 million, up 142.19% from the prior year.
- Capital Expenditures came in at $10.8 million for Q1 2026 at Vireo Growth, up from $9.9 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $13.7 million in Q3 2025 to a low of $152079.0 in Q3 2023.
- The 5-year median for Capital Expenditures is $2.3 million (2023), against an average of $3.6 million.
- Across the five-year window, Capital Expenditures plunged 90.9% in 2023 and soared 3112.91% in 2024, its largest moves.
- Vireo Growth's Capital Expenditures stood at $623076.0 in 2022, then surged by 274.33% to $2.3 million in 2023, then climbed by 16.62% to $2.7 million in 2024, then soared by 262.57% to $9.9 million in 2025, then grew by 9.51% to $10.8 million in 2026.
- The last three Capital Expenditures figures came in at $10.8 million (Q1 2026), $9.9 million (Q4 2025), and $13.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 8.83 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.04 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn | 10.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.80 Mn |
| Mar 31, 2026 | 10.80 Mn |
| Dec 31, 2025 | 9.86 Mn |
| Dec 31, 2025 | 9.86 Mn |
| Sep 30, 2025 | 13.66 Mn |
| Sep 30, 2025 | 13.66 Mn |
| Jun 30, 2025 | 3.70 Mn |
| Jun 30, 2025 | 3.70 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 2.72 Mn |
| Dec 31, 2024 | 2.72 Mn |
| Sep 30, 2024 | 4.89 Mn |
| Sep 30, 2024 | 4.89 Mn |
| Jun 30, 2024 | 3.19 Mn |
| Jun 30, 2024 | 3.19 Mn |
| Mar 31, 2024 | 899,264.00 |
| Mar 31, 2024 | 899,264.00 |
| Dec 31, 2023 | 2.33 Mn |
| Dec 31, 2023 | 2.33 Mn |